Daan Gene Co., Ltd
达安基因
002030
Shenzhen Stock Exchange
Company Profile
1.R&D platform Based on independent innovation platform, the company has been building a research institute without walls. The company has built nucleic acid diagnosis platform, sequencing diagnosis platform, biochip platform, immunology diagnosis platform, cytology diagnosis platform, biochemical diagnosis platform and other emerging and advanced diagnosis technology platforms, forming a leading R&D platform in China. Over the years, it has undertaken a number of national, ministerial, provincial, municipal and other major specialized research project in the field of biotechnology. Meanwhile, the platform is also the pharmaceutical bioengineering research center of the Ministry of health National; local joint engineering laboratory; provincial and municipal technology R&D center. What's more, it has established a multi-level scientific research platform together with domestic and foreign scientific research institutions, universities, enterprises, and hospitals. 2.Industrialization platform Daan Gene is a leading enterprise in the domestic molecular diagnostics industry, with a comprehensive and efficient product development, registration, production, and quality control system. This has formed a self-developed, fully integrated, and leading domestic nucleic acid testing technology platform. Furthermore, after years of meticulous planning, the company has established a comprehensive and leading domestic diagnostic product portfolio, encompassing a wide range of products, including Quantitative PCR, Sequencing, Mass Spectrometry, Chemiluminescence, Immunosorbent Assay, ELISA, Colloidal Gold, Point-of-Care (POCT), and Biochemical products. Its instrument portfolio includes Real-Time Quantitative PCR analyzers, fully automated Nucleic Acid Detection and Analysis systems, Digital PCR instruments, Electro-chemical Gene Chip Detectors, High-Throughput Sequencers, Liquid Chromatography-Tandem Mass Spectrometry Systems, Fully Automated Chemiluminescence Immunoassay Analyzers, Fully Automated Biochemical Analyzers, and Fluorescence Immunochromatography Analyzers. The company's robust production capacity for reagents, instruments, and supporting consumables ensures the timely and high-quality delivery of its products to customers, fully meeting market demand. The company boasts a rich product portfolio. The company and its subsidiaries hold over 700 Class II and Class III medical device registration certificates and hundreds of invention patents. 3.Multi Brand platform The company already boasts a diverse product line, encompassing instruments and testing pipelines, with Daan Gene at its core, as well as Pathology products, Chemiluminescence Immunoassays, Time-of-Flight Mass Spectrometer (TRF), public health, infectious diseases, eugenics, precision medicine, blood screening, and scientific research services. In the domestic market, the company boasts the industry-leading "Daan Gene" brand, the market-leading "Darui Bio" brand, and the regionally dominant "Zhongshan Bio." In the field of biochemical immunoassays, the company is focusing on developing the "DaTai Bio" brand. By establishing and implementing a multi-brand, parallel, and specialized development strategy, the company has forged a strong market synergy, consolidating and enhancing its competitive edge in the Chinese diagnostics market. 4.Market network platform The company adheres to the philosophy of “market-oriented” and “creating value for customers”. The company has established DAAN Marketing System with its own characteristics, and work continuously to improve its operation through building win-win Sales Platform and National Network Service Platform. Currently, we have built Bases in every province to support the local marketing operation. The established three-level operation system, “headquarters-province-county Network’’, is a national business network with strong salesforce and efficient service covering the business field of products sales, diagnosis services and diagnostic technology services. At the same time, the company is accelerating the construction of its sales network in the international market. 5.Industrial chain development platform Focusing on clinical diagnosis technology and products, based on company's platform resources, adhering to the mode of promoting the development of industrial chain through industrial investment, according to the working principle of combining benefit and efficiency, promoting innovation and extending the company's industrial layout, the company has formed an advantage with strong industrial integration and expansion ability, and also consolidates its development prospects. 6.Cultural platform The company has implemented the company culture system, insisting its management concept of “simple, sunny, standardized, efficient and responsible”, making the concept of “sharing growth value” deeply rooted in every member. It is a solid philosophy for the goal of building a “Centennial DAAN GENE”.
Full description
Daan Gene Co., Ltd. is a biomedical high-tech enterprise with molecular diagnostic technology as the main focus, integrating the development, production, and sales of clinical test reagents, instruments, and supporting consumables. The company's products are based on molecular diagnostic technology, immunological diagnostic technology, biochemical technology, POCT technologies, etc. The products involve infectious disease detection, torch, precision medicine, blood screening, public health and scientific research services. Multiple product lines are deployed by Daan Gene and have made a comprehensive layout of IVD diagnosis industry. The strategic goal of the company is to become China’s first-class and internationally well-known integrated supplier of in vitro diagnostics industry which provides upstream and downstream products. The company has been devoting to clinical diagnostic technology and product R&D and has formed an industrial chain development model which combines innovation, scientific research with industrial investment. This development model is highly consistent with the strategic goal of the company. For 30 years development, the business scope of the company has covered many fields, from medical equipment, medical services, elderly care, food safety to industrial investment, etc., continuously extending the company's industrial layout. The main products of the company are as follows: 1.PCR diagnostic product (Clinical): Detection Kit for 2019 Novel Coronavirus (2019-nCoV) RNA (PCR-Fluorescence Probing), Diagnostic Kit for Quantification of Hepatitis B Virus DNA (PCR-Fluorescence Probing), Diagnostic Kit for HMPV Nucleic Acid (PCR-Fluorescent Probing),Diagnostic Kit for Rhinovirus Nucleic Acid (PCR-Fluorescent Probing), Human Bocavirus Nucleic Acid Detection Kit (PCR-Fluorescent Probing), Herpes Simplex Virus Type 2 Nucleic Acid Detection Kit (PCR-Fluorescent Probing), Human Papillomavirus (20 types) Genotyping Detection Kit (PCR-Electrochemical Gene Chip Method), CYP2C19 Genotyping Detection Kit (PCR-Fluorescence Probing), CYP3A5 Genotyping Detection Kit (PCR-Fluorescence Probing) and other series of testing products. 2.PCR diagnostic product line (Public Health): Detection Kit for Novel Coronavirus Mutations (PCR Fluorescent Probing), Detection Kit for Influenza A/B (PCR-Fluorescence Probing), Detection Kit for Group A Rotavirus/Norovirus (Dual Channel) (PCR Fluorescent Probing), Detection Kit for Anthrax Bacillus (PCR Fluorescent Probing), Detection Kit for Zika, Dengue, and Chikungunya Viruses (PCR Fluorescent Probing), Detection Kit for Rickettsia of Tick-borne Spotted Fever (PCR Fluorescent Probing) and other series of testing products. 3.Sequencing series products: Detection Kit for Drug-Resistant Gene Mutations of Hepatitis B Virus (PCR-Sequencing Method), Detection Kit for Genotyping of Hepatitis C Virus (PCR-Sequencing Method), Detection Kit for Drug Resistance Genotyping of Human Immunodeficiency Virus 1 (HIV-1) (PCR-Sequencing Method), Detection Kit for Isoniazid-Resistant Gene of Mycobacterium tuberculosis (Sequencing Method), Detection Kit for UGT1A1 Gene Polymorphism (PCR-Sequencing Method), Detection Kit for EGFR Gene Mutations (Sequencing Method), and other major infectious diseases, pharmacogenomics, oncology and other series of testing products. 4.Chemiluminescence series products: Detection Kit for Alpha-Fetoprotein Quantitative Determination (Chemiluminescent Immunoassay), Carcinoembryonic Antigen Quantitative Determination (Chemiluminescent Immunoassay), Hepatitis B Virus Surface Antibody (Chemiluminescent Immunoassay), and Pregnancy-Associated Plasma Protein A Determination (Chemiluminescent Immunoassay) are included in the series of testing products covering tumor markers, hepatitis B, sex hormones, and prenatal screening. 5.Time-Resolved Series Products: Quantitative Determination Reagent Kit for Alpha-Fetoprotein (Time-Resolved Immunofluorescence), Quantitative Determination Reagent Kit for Carcinoembryonic Antigen (Time-Resolved Immunofluorescence), Quantitative Determination Reagent Kit for Phenylalanine in Newborns (Fluorescence Analysis), and other related testing products. 6.ELISA products:Novel coronavirus (2019-nCoV) antigen detection kit (colloidal gold method)、 Detection Kit for EB Virus Capsid Antigen (VCA) IgA Antibody (Enzyme-Linked Immunoassay), Detection Kit for Rapid Malaria (Immunochromatographic Assay),and other related products. 7.Biochemical Series Products: Total Protein Determination Reagent Kit (Biuret Method), Alanine Aminotransferase Determination Reagent Kit (Lactate Dehydrogenase Method), Urea Determination Reagent Kit(Ultraviolet-Glutamate Dehydrogenase Method), Cystatin C Determination Reagent Kit (Latex Immunoturbidimetric Assay), Total Cholesterol Determination Reagent Kit (Oxidase method), Immunoglobulin A Determination Reagent Kit (Immunoturbidimetric Assay), Inorganic Phosphorus Determination Reagent Kit (Phosphomolybdate Method), and other related testing products. 8.Mass Spectrometry Series Products: Various Amino Acids, Carnitine, and Succinylacetone Determination Reagent Kit (Tandem Mass Spectrometry), 25-Hydroxyvitamin D Determination Reagent Kit (Tandem Mass Spectrometry), Fat-Soluble Vitamin Testing (Tandem Mass Spectrometry), Water-Soluble Vitamin Testing (Tandem Mass Spectrometry), Immunosuppressant (tandem mass spectrometry), and other related products covering newborn genetic metabolic disease screening, vitamin testing, and drug concentration monitoring. 9.Instrument products: Sample Processing System, Nucleic acid extraction instrument, CR Thermal Cycler, Real-time PCR Detection System, Electrochemical Gene Chip Analyzer, High-throughput Sequencer, Fully Automated Chemiluminescence Immunoassay Analyzer, Liquid Chromatography Tandem Mass Spectrometry System, Automatic Lid Opener, Digital PCR Instrument, Our agent's brand of fluorescent quantitative PCR instrument of Distributor brand, nucleic acid extraction instrument, liquid suspension chip analyzer, etc. 10.Sample collection series products: Disposable sampling device, sample preservation solution, sample releasing reagent (swab type), etc. 11.Extraction and Preservation Reagents: Nucleic Acid Extraction Kit (Magnetic Bead), RNA/DNA Purification Kit (Spin Column). 12.Testing service: independent medical laboratory provides medical testing, health consulting and management services, such as genetic susceptibility testing, tumor markers testing, cervical cancer screening, routine physical examination and other health services. 13.Scientific research service: Molecular Diagnosis and Therapy, a core journal of science and technology.